Inhibitory Effect of the HASPIN Inhibitor CHR-6494 on BxPC-3-Luc, A Luciferase-Expressing Pancreatic Cancer Cell Line.

Tanaka, Hiromitsu; Nishida-Fukuda, Hisayo; Wada, Morimasa; Tokuhiro, Keizo; Matsushita, Hiroaki; Ando, Yukio

Tanaka, Hiromitsu; Nishida-Fukuda, Hisayo; Wada, Morimasa; Tokuhiro, Keizo; Matsushita, Hiroaki; Ando, Yukio.

Afiliación

Tanaka H; Faculty of Pharmaceutical Sciences, Nagasaki International University, Huis Ten Bosch, Sasebo, Nagasaki, Japan. Email: h-tanaka@niu.ac.jp.
Nishida-Fukuda H; Department of Genome Editing, Institute of Biomedical Science, Kansai Medical University, Shin-machi, Hirakata City, Osaka, Japan.
Wada M; Faculty of Pharmaceutical Sciences, Nagasaki International University, Huis Ten Bosch, Sasebo, Nagasaki, Japan.
Tokuhiro K; Department of Genome Editing, Institute of Biomedical Science, Kansai Medical University, Shin-machi, Hirakata City, Osaka, Japan.
Matsushita H; Faculty of Pharmaceutical Sciences, Nagasaki International University, Huis Ten Bosch, Sasebo, Nagasaki, Japan.
Ando Y; Faculty of Pharmaceutical Sciences, Nagasaki International University, Huis Ten Bosch, Sasebo, Nagasaki, Japan.

Cell J ; 24(4): 212-214, 2022 Apr.

Article en En | MEDLINE | ID: mdl-35674022

Palabras clave

HASPIN Kinase; Histone H3; Pancreatic Cancer; Protein Kinase

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cell J Año: 2022 Tipo del documento: Article Pais de publicación: Irán